Rubella immunity status and the active offer of MMR/MMRV vaccination during pregnancy

Abstract

References

1. WHO European Region. Regional Committee for Europe – Fifty-fifth session. Resolution: Strengthening national immunization systems through measles and rubella elimination and prevention of congenital rubella infection in WHO’s European Region. Bucharest, Romania, 12–15 September 2005. Available from: http://www.euro.who.int/ data/assets/pdf file/0003/88086/RC55eres07.pdf [accessed 20.09.19].
2. WHO European Region. Regional Committee for Europe – Sixtieth session. Resolution: Renewed commitment to elimination of measles and rubella and prevention of congenital rubella syndrome by 2015 and Sustained support for polio-free status in the WHO European Region. Moscow, 13–16 September 2010. Available from: http://www.euro.who.int/ data/assets/pdffile/0016/122236/RC60 eRes12.pdf [accessed 20.09.19].
3. Piano Nazionale Prevenzione Vaccinale 2017-2019. Available from: http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf [accessed 12.05.2019]
4. Ministerial circular 11.12.2019. Recommended vaccination for childbearing and pregnant women. Available from http://www.trovanorme.salute.gov.it/norme/ [accessed 1.31. 2020]
5. Giambi C., Montano-Remacha C., Pastore Celentano L.,Derrough T.: Surveillance of congenital rubella and rubella infections in pregnancy in EU/EEA countries, 2012: Current status and future perspective to monitor elimination. Vaccine 33:4929-4937, 2015
6. Filia A., Rota MC, De Manso M., D’Ancona P., Giambi C., Ranghiasci A., Salmaso S., Iannazzo S., Pompa MG, Declich S e Gruppo di lavoro sul Piano nazionale di eliminazione del morbillo e della rosolia congenita. Piano Nazionale di eliminazione del morbillo e della rosolia congenita: indagine sullo stato di avanzamento (2009). Roma Istituto Superiore di Sanità. Rapporti ISTISAN 10/45
7. DM 16 luglio 2001: “Modificazioni al certificato di assistenza al parto, per la rilevazione dei dati di sanità pubblica e statistici di base relativi agli eventi di nascita, alla nati-mortalità ed ai nati affetti da malformazioni". GU n. 218 del 19/9/2001
8. Provincia di Trento. Piano Provinciale di Prevenzione 2007-2009. Available from: https://www.trentinosalute.net/Temi [Accessed 12.18.2019]
9. Sistema Nazionale Linee Guida: Gravidanza Fisiologica. Aggiornamento 2011. Available from: http://www.salute.gov.it/imgs/C_17_pubblicazioni_1436_allegato.pdf
10. Robinson JL, Lee BE, Preiksaitis JK, Plitt S, Tipples GA. Prevention of congenital Rubella Syndrome – What makes sense in 2006?. Epidemiol Rev 2006; 28:81-87
11. Lo Giudice D, Cannavò G, Capua A, Grillo OC, La Fauci V, Puliafito A, Sindoni D, Squeri R, Calimeri S. Eliminating congenital rubella: a seroepidemiological study on women of childbearing age and MMR vaccine coverage in newborns. J Prev Med Hyg. 2009 Dec;50(4):236-40.
12. Calimeri S, Capua A, La Fauci V, Squeri R, Grillo OC, Lo Giudice D. Prevalence of serum anti-rubella virus antibodies among pregnant women in southern Italy. Int J Gynaecol Obstet. 2012 Mar;116(3):211-3.
13. Lo Giudice D, Capua A, La Fauci V, Squeri R, Grillo OC, Calimeri S. Congenital rubella syndrome and immunity status of immigrant women living in southern Italy: a cross-sectional, seroepidemiological investigation. Travel Med Infect Dis. 2014 May-Jun;12(3):253-7.
14. Lancia A, Vazzoler C, Arrivi F, Pettinicchio V, Marzani S, Trinito MO. The evaluation of susceptibility to rubella in women of childbearing age; the experience of the Asl Roma C. Ig Sanita Pubbl. 2014 Mar-Apr;70(2):247-54.
15. Facciolà A, Squeri R, Genovese C., Alessi V,. La Fauci V. Perception of rubella risk in pregnancy: an epidemiological survey on a sample of pregnant women Ann Ig 2019; 31 (Suppl 1): 65-71
16. World Health Organization. Eliminating measles and rubella and preventing congenital rubella infection. WHO European Region strategic plan 2005-2010. Available from: http:// www.euro.who.int/Document/E87772.pdf [accessed 20.10.19]
17. Pandolfi E., Gesualdo F., Rizzo C. Bella A., Agricola E., Mastroiacovo P., Tozzi AE.: Global seroprevalence of rubella among pregnant and childbearing age women: a meta-analysis. The European Journal of Public Health, Vol. 27, No. 3, 530–537
18. Choi R, Oh Y, Oh Y, et al Recent trends in seroprevalence of rubella in Korean women of childbearing age: a cross-sectional study. BMJ open 2020;10:e030873
19. Okuda M, Yamanaka M, Takahashi T et al. Positive rates for rubella antibody in pregnant women and benefit of post-partum vaccination in a Japanese perinatal center. J.Obstet Gynecol Res. 2008; 34 (2):168-173
20. Rota MC, Bella A., Gabutti G., Giambi C., Filia A., Guido M., De Donno A., Crovari P., Ciofi Degli Atti ML. Rubella seroprofile of the Italian population: an 8-year comparison Epidemiol. Infect. (2007), 135, 555–562.
21. De Paschale M., Manco MT., Paganini A., Agrappi C., Mirri P., Cucchi G., Saccani, B. ,Flores D’Arcais A., Clerici P.:Rubella antibody screening during pregnancy in a urban area of northern Italy. Infectious Dis Rep 2012; 4: 59-61
22. Marchi S, Viviani S., Montomoli E., Trombetta CM.: Elimination of congenital rubella: a seroprevalence study of pregnant women and women of childbearing age in Italy. Human Vaccines & Immunotherapeutics, 26 November 2019. Available from: https://www.tandfonline.com/loi/khvi20
23. Boattini M,, Bianco G., Charrier L., Iannaccone M., Masuelli G., Coggiola M., Sacchi A. Pittaluga F., Cavallo R.: Rubella serosurvey and factors related to vaccine hesitancy in childbearing women in Italy. Preventive Medicine Reports 15: 1-6 (2019)
24. Santoro V., Pettinicchio V., Lamncia A., Vazzoler C., De Luca F. Franco E.: The active offering of measles, rubella and mumps vaccine in new mothers: the experience of health facilities in one of the Local Health Unit of Rome. Ig. Sanità Pubbl, 2016 nov-dec;72 (6):589-597.
25. Sorveglianza Rosolia congenita e in gravidanza news. Available from http://www.epicentro.iss.it/problemi/rosolia/bollettino.asp
26. Doret M, Marcellin L. Vaccination in the early post-partum: Guidelines. J Gynecol Obstet Biol Reprod (Paris). 2015 Dec;44(10):1135-40.
27. Wilson R., Paterson P, Larson HJ. Strategies to improve maternal vaccination acceptance. BMC Public Health 2019;19:342
28. Ferraroni E., Volta A., Capuano C., Fragni G., Novelli D.: Prevenzione delle rosolia: vaccinazione nel post partum in un punto nascita di primo livello. Medico e Bambino 4:1-4, 2007. Web pages. Available from https://www.medicoebambino.com/-donne_rosolia_vaccinazione_sieronegative_gravidanza
29. Leonardi G., Campra D., Silano V., Gaggero M., Boscardini L., Fobelli S.. Guala A.: Recupero vaccinale antirosolia nel post partum. Medico e Bambino 7:1-5, 2008. Available from: https://www.medicoebambino.com/index.php
30. Lutz CS, Carr W, Cohn A, Rodriguez L. Understanding barriers and predictors of maternal immunitazion: identifying gaps through an exploratory literature review. Vaccine; 2018 (36):7445-7455.